Scholar Rock Holding (SRRK) Accumulated Expenses (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Accumulated Expenses of $44.3 million in Q1 2026, up 120.49% quarter-over-quarter from $20.1 million in Q4 2025, and up 428.85% on a YoY basis from $8.4 million in Q1 2025.

Scholar Rock Holding (SRRK) Accumulated Expenses (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Accumulated Expenses history runs 10 years deep, the most recent figure standing at $44.3 million for Q1 2026.

  • In Q1 2026, Accumulated Expenses rose 428.85% year-over-year to $44.3 million; the TTM figure through Mar 2026 stood at $44.3 million (up 428.85% YoY), while the FY2025 annual figure was $20.1 million, down 35.26% from the prior year.
  • Accumulated Expenses was $44.3 million for Q1 2026 at Scholar Rock Holding, up from $20.1 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $44.3 million in Q1 2026 to a low of $4.0 million in Q1 2023.
  • Historically, Accumulated Expenses has averaged $18.8 million across 5 years, with a median of $17.9 million in 2022.
  • The sharpest annual moves came in 2022 and 2026: Accumulated Expenses sank 63.25% in 2022, then jumped 428.85% in 2026.
  • A 5-year view of Accumulated Expenses shows it stood at $6.8 million in 2022, then surged by 200.72% to $20.4 million in 2023, then surged by 51.92% to $31.1 million in 2024, then plunged by 35.26% to $20.1 million in 2025, then surged by 120.49% to $44.3 million in 2026.
  • The last three Accumulated Expenses figures came in at $44.3 million (Q1 2026), $20.1 million (Q4 2025), and $22.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Scholar Rock Holding 6.03 Bn 5.55 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 44.35 Mn
Dec 31, 2025 20.11 Mn
Sep 30, 2025 22.74 Mn
Jun 30, 2025 44.12 Mn
Mar 31, 2025 8.39 Mn
Dec 31, 2024 31.07 Mn
Sep 30, 2024 29.26 Mn
Jun 30, 2024 21.89 Mn
Mar 31, 2024 6.11 Mn
Dec 31, 2023 20.45 Mn
Sep 30, 2023 17.40 Mn
Jun 30, 2023 13.81 Mn
Mar 31, 2023 4.05 Mn
Dec 31, 2022 6.80 Mn
Sep 30, 2022 6.58 Mn
Jun 30, 2022 17.89 Mn
Mar 31, 2022 4.47 Mn
Dec 31, 2021 17.46 Mn
Sep 30, 2021 17.90 Mn
Jun 30, 2021 15.45 Mn